Siemens Healthineers sets new sustainability benchmark as first IVD manufacturer to earn My Green Lab ACT Ecolabel for analyzers, reagents
Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 immunoassay and clinical chemistry reagents used globally by medical laboratories for in vitro diagnostic testing.
The company is the first to earn certification for both reagents and analyzers in its Atellica portfolio. Notable assays with the certification include its High-Sensitivity Troponin I assay, which is the first available assay in the U.S. to aid heart attack diagnosis and aid in identifying future risk of death and cardiac events, and its Enhanced Liver Fibrosis (ELF) Test, the first prognostic test used to help assess the likelihood of disease progression in patients with advanced fibrosis due to metabolic dysfunction-associated steatohepatitis (MASH).
The reagents were rigorously evaluated and independently certified through My Green Lab’s comprehensive assessment process. This globally recognized standard provides transparent, third-party verified environmental impact data for laboratory consumables, chemicals, and equipment. The ACT Ecolabel evaluates products across key environmental impact categories—including manufacturing practices, energy and water consumption, chemicals, waste, and packaging—and distills this information into a total score that helps scientists and procurement experts better evaluate the sustainability of products for their healthcare facilities.
In its continual pursuit of more sustainable IVD manufacturing, Siemens Healthineers also now ships specialty laboratory reagents with new packaging that reduces volume and replaces plastic inlays with cardboard, expected to reduce 39 annual tons of polystyrene plastics and saving 161 tons of CO2—the equivalent weight of 20 cars and annual energy use of 18 average U.S. homes.
